Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose
|
|
- Joseph Smith
- 6 years ago
- Views:
Transcription
1 Originl Pper Received: June 4, 2015 Accepted: August 18, 2015 Published online: October 20, 2015 Femorl Access nd Delivery of Continuous Renl Replcement Therpy Dose Rinldo Bellomo, b John Mårtensson b, c Serigne Lo d Kirsi-Mij Kukonen Aln Css e Mrtin Gllgher d for the RENAL study investigtors nd the Austrlin nd New Zelnd Intensive Cre Clinicl Trils Group Austrlin nd New Zelnd Intensive Cre Reserch Centre (ANZIC-RC), Deprtment of Epidemiology nd Preventive Medicine, Monsh University, The Alfred Centre, Level 6, Melbourne, Vic., nd b Deprtment of Intensive Cre, Austin Hospitl, Heidelberg, Vic., Austrli; c Section of Anesthesi nd Intensive Cre Medicine, Deprtment of Physiology nd Phrmcology, Krolinsk Institutet, Soln, Sweden; d The George Institute for Globl Helth, University of Sydney, Level 13, Sydney, N.S.W., nd e Menzies School of Helth Reserch, Chrles Drwin University, Drwin, Winnellie, N.T., Austrli Key Words Dilysis Continuous renl replcement therpy Ctheters Femorl vein Intensive cre Abstrct Aims: The study ims to describe the use of dilysis ctheters in criticlly ill ptients treted with continuous renl replcement therpy (CRRT) nd to study the impct of femorl versus non-femorl ccess on CRRT dose. Methods: Sttisticl nlysis nd predictive modelling of dt from the Rndomized Evlution of Norml vs. Augmented Level renl replcement therpy tril. Results: The femorl vein ws the first ccess site in 937 (67%) of 1,399 ptients. These ptients hd higher Acute Physiology nd Chronic Helth Evlution nd Sequentil Orgn Filure Assessment scores (p = 0.009) nd lower ph (p < 0.001) but similr mortlity to ptients with non-femorl ccess (44 vs. 45%; p = 0.63). Lower body weight ws independently ssocited with femorl ccess plcement (OR 0.97, 95% CI ). Femorl ccess ws ssocited with 1.03% lower CRRT dose (p = 0.05), but 4.20% higher dose ws chieved with 13.5 Fr ctheters (p = 0.03). Conclusions: Femorl ccess ws preferred in lighter nd sicker ptients. Ctheter guge hd greter impct thn ctheter site in CRRT dose delivery. Video Journl Club Cppuccino with Cludio Ronco t S. Krger AG, Bsel Introduction The bility to mintin ptient homeostsis of wter, wste products, electrolytes nd cid-bse during continuous renl replcement therpy (CRRT) is dependent on CRRT circuit ptency over time [1]. The qulity of vsculr ccess influences the bility to chieve dequte nd relible blood flow through the circuit, mjor determinnt of circuit life spn. Ctheter dysfunction requiring A complete list of investigtors in the RENAL study is provided in the supplementry mteril (online suppl. item S1; for ll online suppl. mteril, see E-Mil krger@krger.com S. Krger AG, Bsel /15/ $39.50/0 Prof. Rinldo Bellomo Deprtment of Intensive Cre, Austin Helth 145 Studley Rod Heidelberg, VIC 3084 (Austrli) E-Mil ustin.org.u
2 ctheter replcement nd/or cusing circuit filure occurs in pproximtely 10% of ptients treted with CRRT [2, 3]. Such circuit filures induce interruptions in tretment, which decrese the delivered CRRT dose nd uremic control [4]. Moreover, they significntly increse nursing worklod nd tretment costs [5]. Thus, both choice of optiml insertion site nd ctheter chrcteristics re importnt to delivering optiml therpy. There is uncertinty regrding the optiml site of ctheter insertion for CRRT in criticlly ill ptients. Femorl vein ctheteriztion my be fster nd esier thn jugulr vein ctheteriztion [6] but my impede mobiliztion [7]. Thus, recent guidelines fvor the right jugulr vein in preference to femorl veins [8]. These recommendtions re, however, not supported by robust evidence. Furthermore, the impct of ctheter brnd, guge nd length on the delivery of CRRT hs only been investigted in smll studies nd no robust evidence exists to guide choice of ctheter. The Rndomized Evlution of Norml vs. Augmented Level of Replcement Therpy (RENAL) study collected detiled informtion on dilysis ctheter chrcteristics, site of ctheter insertion nd circuit nticogultion during CRRT nd therefore offers unique opportunity to explore the reltionship between these fctors nd delivered CRRT dose [9 11]. Accordingly, we imed to describe the use of temporry dilysis ctheters in intensive cre unit (ICU) ptients treted with CRRT. In prticulr, we sought to identify fctors ssocited with choosing the femorl vein s first site of ctheter insertion nd to explore the ssocition of first insertion site (femorl vs. non-femorl) nd different ctheter chrcteristics with delivered CRRT dose during the first full dy of tretment. Mterils nd Methods Study Protocol The RENAL study ws prospective, multicenter, rndomized, controlled tril compring higher (40 ml/kg/h) versus lower (25 ml/kg/h) CRRT dose in 1,508 criticlly ill ptients. The Humn Reserch Ethics Committees of the University of Sydney nd of ll prticipting institutions pproved the study. Written informed consent ws obtined from ptients or next of kin. Adult ptients ( 18 yers) with severe AKI requiring cute RRT were included if they met t lest one of the following criteri: oliguri (urine output <100 ml during 6 h not responding to fluid resuscittion), hyperklemi (serum potssium >6.5 mmol/l), severe cidosis (ph <7.2), serum ure level >25 mmol/l, serum cretinine level >300 μmol/l or the presence of cliniclly significnt orgn edem. Ptients with previous RRT during the sme hospitliztion or those with end-stge renl filure requiring chronic dilysis were excluded. A detiled study protocol is found in the ppendix of the originl study [11]. The primry end point ws 90-dy mortlity. Secondry end points included RRT-free dys, mechnicl ventiltion-free dys, ICU-free dys nd hospitl-free dys t 90-dy follow-up. The site of dilysis ctheter insertion, ctheter choice nd mode of circuit nticogultion were determined by the treting physicin. For the purpose of the present study, the delivered CRRT dose (s percentge of prescribed dose) during the first complete 24-hour dy ws recorded. Sttisticl Anlysis Dt ws nlyzed by using SAS softwre version 9.1. Continuous vribles were expressed s men (SD) nd ctegoricl vribles s numbers (%). The Student t test or the Mnn Whitney test ws used to compre continuous vribles. The χ 2 test or the Fisher s exct test ws used to compre ctegoricl vribles. Multivrite logistic regression nlysis ws used to study the ssocition of hving the femorl vein s first site of ctheter insertion. Bseline vribles were considered nd were included in the multivrite model if they were sttisticlly significnt t p vlue <0.20 in the univrite nlysis. The ssocition between using femorl ctheter (vs. non-femorl ctheter) nd CRRT dose during the first complete 24 h ws ssessed by multivrite liner regression nlysis. The following potentil confounders were considered: tretment group, bseline chrcteristics, illness severity, ctheter guge, ctheter length, ctheter brnd, CRRT mchine nd nticogultion mode. Covrites were included in the multivrite model if they were sttisticlly significnt t p vlue <0.20 in the univrite nlysis. In the finl nlyses, 2-sided p vlue <0.05 ws considered sttisticlly significnt. Results First Site of Ctheter Insertion Of the 1,508 rndomized ptients in the RENAL tril, dt on first dilysis ctheter insertion site ws vilble for 1,399 (93%) ptients. In 937 (67%) of these 1,399 ptients the femorl vein ws chosen s the first site of dilysis ctheter insertion ( fig. 1 ). The right femorl vein ws preferred over the left. Jugulr ccess ws used in 351 (25%) ptients nd subclvin ccess ws chosen in 111 (8%) ptients. Fctors Associted with Femorl Vein Ctheteriztion Demogrphics, dmission dignosis, time from ICU dmission to rndomiztion, tretment group, bseline biochemistry nd outcomes for ptients with femorl nd non-femorl vein s first site of dilysis ctheter insertion re detiled in tble 1. Ptients receiving femorl ccess weighed on n verge 3.8 kg less thn ptients receiving non-femorl ccess (p < 0.001; tble 1 ) nd hd higher Acute Physiology nd Chronic Helth Evlution (APACHE) III scores, crdiovsculr Sequentil Orgn Filure Assessment scores, hemoglobin levels nd chlo- 12 Bellomo et l.
3 Tble 1. Chrcteristics of ptients ccording to first site of ctheter insertion Chrcteristic Femorl (n = 937) Non-femorl (n = 462) p vlues Age, yers 64.3± ± Mle sex 593 (63.3) 307 (66.5) 0.3 APACHE III score (25.7) (25.4) 0.02 Time from ICU dmission to rndomiztion, h 46.1± ± Rndomized to high CRRT intensity 456 (48.7) 236 (51.1) 0.40 Estimted glomerulr filtrtion rte, ml/min 57.5± ± Body weight, kg 79.5± ±13.4 <0.001 Mechnicl ventiltion 681 (72.7) 356 (77.1) 0.08 Severe sepsis t bseline 473 (50.5) 213 (46.1) 0.1 Non-opertive dmission dignosis 695 (74.2) 303 (65.6) 0.6 Opertive dmission dignosis 242 (25.8) 159 (34.4) 0.6 Severe cidemi (ph <7.2) 361 (38.5) 132 (28.6) <0.001 Severe orgn edem 421 (44.9) 200 (43.3) 0.6 Crdiovsculr SOFA score 2.9 (1.5) 2.7 (1.6) INR, % 1.8± ± APTT, s 45.8± ± Hemoglobin, g/l 100.7± ± Pltelet count, 10 9 /l 183.6± ± Sodium, mmol/l 137.3± ± Chloride, mmol/l 105.0± ± CRRT dose during the first complete 24 h, ml/kg/h 27.5± ± Delivered/prescribed CRRT dose during the first complete 24 h, % 85.4± ± Durtion first ctheter/totl CRRT time, % 96.6± ± Deth in ICU 328 (35.0) 151 (32.7) 0.4 Deth t dy (43.8) 208 (45.1) 0.6 Vribles re given s men ± SD or s numbers (percentge). APTT = Activted prtil thromboplstin time; INR = interntionl normlized rtio. ride levels. CRRT ws initited 46.5 h fter ICU dmission in ptients with femorl ccess nd fter 62.5 h in ptients with non-femorl ccess (p = 0.02). The first femorl ccess ws used during 96.6% of the totl CRRT time nd the first non-femorl ccess ws used during 94.5% of the totl CRRT time (p = 0.58; tble 1 ). Overll, 410 (44%) ptients with femorl dilysis ctheter s first ccess hd died t 90 dys fter rndomiztion compred with 208 (45%) non-femorl ccess ptients ( tble 1 ). Severl fctors were ssocited with greter likelihood of the use of femorl vein s the first site of ctheter insertion on univrite logistic regression nlysis. On multivrite logistic regression nlysis, however, only body weight (OR 0.97 for ech kg increse, 95% CI ), sodium levels (OR 0.93 for ech mmol increse, 95% CI ) nd chloride levels (OR 1.08 for ech mmol increse, 95% CI ) were independently ssocited with choosing the femorl vein s the first site of ccess ( tble 2 ). Right femorl vein Left femorl vein Right jugulr vein Left jugulr vein Left subclvin vein Right subclvin vein First site of dilysis ctheter insertion (%) Fig. 1. Site of first temporry dilysis ctheter insertion in the RENAL tril (n = 1,399). Femorl Access nd Delivery of CRRT Dose 13
4 Tble 2. Univrite nd multivrite logistic regression nlysis of femorl vein s first site of ctheter insertion Vribles Univrite nlysis Multivrite nlysis OR (95% CI) p vlues OR (95% CI) p vlues Body weight, kg ( ) < ( ) <0.001 Sodium, mmol/l ( ) ( ) <0.001 Chloride, mmol/l ( ) ( ) <0.001 Adjusted for bseline chrcteristics with p < 0.20 in the univrite nlyses. Only vribles with p < 0.05 in the multivrite nlysis re shown. <15 cm p < Femorl (n = 899) Non-femorl (n = 448) 11.5 Fr 12 Fr p = Femorl (n = 911) Non-femorl (n = 448) cm 12.5 Fr cm 13 Fr 13.5 Fr 24 cm 14 Fr Ptients (%) b Ptients (%) Nigr Heprin Arrow Gmcth None Edwrds Other p < Femorl (n = 926) Non-femorl (n = 451) Other p > 0.05 Femorl (n = 846) Non-femorl (n = 425) c Ptients (%) d Ptients (%) Fig. 2. Length ( ), guge ( b ) nd brnd ( c ) of dilysis ctheter s well s circuit nticogultion ( d ) during CRRT in the RENAL tril ccording to first site of ctheter insertion. Ctheter Chrcteristics nd Circuit Anticogultion Longer ctheters were generlly used for femorl ccess, wheres shorter ctheters tended to be inserted in nonfemorl sites ( fig. 2 ). A 13.5-Fr ctheter ws most commonly chosen for both femorl (68%) nd non-femorl ccess (59%; fig. 2 b). Longer nd greter guge Nigr (Brd, Murry Hill, N.J., USA) ctheters were minly used in the femorl (62%) nd non-femorl (53%) group ( fig. 2 c). Informtion on circuit nticogultion ws vilble for 1,271 (91%) ptients. Heprin ws used in 487 (58%) 14 Bellomo et l.
5 Tble 3. Multivrite liner regression showing the ssocition with delivered CRRT dose (s % of prescribed dose) during the first complete 24-hour period Vrible Coefficient, ±SE p vlues Femorl ctheter (vs. non-femorl) 1.03± French ctheter (vs. other guges) 4.20± or 24-cm ctheter (vs. other lengths) 1.88± Rndomized to higher CRRT intensity 26.32±1.27 <0.001 Adjusted for ge, sex, APACHE III score, body weight, oliguri, hyperklemi, cidemi, oedem, ure, cretinine, ctheter brnd, CRRT mchine use nd mode of circuit nticogultion. of 846 of ptients in the femorl group nd 269 (63%) of 425 ptients in the non-femorl group. CRRT ws delivered without circuit nticogultion in high proportion of ptients with femorl (41%) nd non-femorl (36%) ctheters (p = 0.50; fig. 2 d). Fctors Associted with Delivered CRRT Dose during the First 24 h A totl of 456 (48.7%) ptients with femorl ccess were rndomized to high intensity therpy (40 ml/kg/h) compred to 236 (51.1%) ptients with non-femorl ctheter (p = 0.40). On n verge, CRRT intensity during the first complete 24 h ws 27.5 ml/kg/h in the femorl group nd 26.2 ml/kg/h in the non-femorl group (p = 0.01). On n verge, 85.4 nd 81.9% of the prescribed dose (p = 0.002), respectively, ws chieved during this period ( tble 1 ). On multivrite liner regression, djusting for bseline chrcteristics, tretment group, ctheter chrcteristics, CRRT mchine nd mode of circuit nticogultion, the use of femorl ctheter ws ssocited with 1.03% lower CRRT dose (p = 0.05) during the first 24 h thn when non-femorl ctheter ws used ( tble 3 ). In contrst, 4.20% higher CRRT dose ws chieved with 13.5 Fr guge ctheters thn with other ctheter guges (p = 0.03). Finlly, being rndomized to higher intensity CRRT ws independently ssocited with 26.32% lower CRRT dose thn being llocted to lower intensity CRRT. Discussion Key Findings We nlyzed the use of temporry dilysis ctheters, the choice of insertion site, the ctheter guge nd their impct on CRRT dose in criticlly ill ptients enrolled in the RENAL tril. We found tht the femorl vein ws used s the first site of dilysis ctheter insertion in two thirds of ptients nd ws preferentilly chosen in ptients with lower body weight nd in sicker ptients. Using femorl vein for vsculr ccess hd limited impct on the delivered erly CRRT dose during the first 24 h. In contrst, ctheter guge ws more importnt determinnt of delivered CRRT dose during this time frme. Reltionship to Previous Studies Previous studies investigting the impct of vsculr ccess site on delivered RRT dose hve reported inconsistent results. Hryszko et l. [12] found n independent 5-fold higher risk of ctheter dysfunction, defined s inbility to mintin blood flow of t lest 150 ml/h, with femorl s compred to internl jugulr ctheters. In tht study, however, 75% of ptients were fully mobile, nd tretment ws with intermittent hemodilysis. Lingos et l. [13] explored dilysis performnce during >400 intermittent hemodilysis sessions in 81 ptients with cute renl filure. Use of femorl ccess, s compred to non-femorl ccess, ws independently ssocited with lower ure reduction rtio with intermittent hemodilysis. Of note, however, the femorl ctheters used in this study were short, mesuring only 16.5 or 19.5 cm. To optimize blood flow nd CRRT dose nd to void recircultion, it is importnt tht the ctheter tip is plced in lrge vein (externl ilic nd close of inferior ven cv) or in the right trium [5, 14, 15]. Therefore, it is recommended tht 24-cm ctheters be used in the femorl position, nd tht cm ctheters be used for right jugulr cnnultions [16]. In 11 of the 12 centers involved in the French Cthedi study, 16-cm ctheters were used in the jugulr nd 25-cm ctheters in the femorl position [17]. Similrly, 24-cm ctheters were frequently used for femorl (48%) nd 15- to 16-cm ctheters were frequently used for jugulr or subclvin ccess (50%) in the RENAL study ptients. The Cthedi study showed higher rte of ctheterrelted infections with femorl ccess in ptients with Femorl Access nd Delivery of CRRT Dose 15
6 body mss index >28.4 kg/m 2 [17]. Furthermore, the incresed ctheter-relted infections risk in hevier ptients (>90 kg) with femorl dilysis ctheters ws recently confirmed in n observtionl study involving 458 ptients [18]. It is therefore not surprising tht RENAL study ptients receiving right or left femorl ctheteriztion [19] hd lower body weight thn ptients receiving non-femorl ctheteriztion. Implictions of Study Findings Our study suggest tht clinicins perceive the femorl vein to be useful potentil first choice when rpid nd sfe ccess is needed nd in ptients with multilumen centrl venous ctheter in the right jugulr vein [6]. Our results reflect this preference with sicker ptients (more severe cidemi, higher APACHE III nd crdiovsculr Sequentil Orgn Filure Assessment score nd fster initition of CRRT fter ICU dmission) being more likely to hve their first CRRT ctheter inserted in the femorl vein. This, in turn, my reflect the fct tht centrl venous ctheter is often inserted before temporry dilysis ctheter in hemodynmiclly unstble ptients. Under such circumstnces, the femorl route my be the only vilble option. Finlly, we found tht femorl vein is preferred in ptients with lower body weight. Although we did not ssess body hbitus, this finding my reflect the fct tht femorl vein cnnultion my be techniclly difficult nd is therefore voided in obese ptients. In the univrite comprison, the delivered CRRT dose (s percentge of the prescribed dose) ws 3.5% higher through femorl ccess thn through non-femorl ccess ( tble 1 ). A femorl ccess ws, however, ssocited with 1.03% lower CRRT delivery in the multivrite liner regression nlysis. The fct tht higher proportion of ptients with femorl ccess were cnnulted with lrge-guge 13.5 Fr ctheters s compred to ptients with non-femorl ccess (67.5 vs. 59.2%, p = 0.009) likely explins the reversed result in the multivrite djusted nlysis. In fct, fter djusting for severl potentilly importnt confounders of the reltionship between ccess site nd dose, lrger ctheter guge (13.5 Fr) ws independently ssocited with delivery of higher (4.2%) CRRT dose wheres the bility to chieve the prescribed dose ws, s could be expected, impired in ptients llocted to higher intensity CRRT. These findings need to interpreted in the light of the originl RENAL tril results. In the RENAL tril, the high-intensity group received 50% higher CRRT dose thn the low-intensity group. Despite this difference in dose, 90-dy mortlity ws similr in both the groups. Our results therefore suggest tht insertion of 13.5 Fr guge CRRT ctheters in the femorl vein of very sick criticlly ill ptients hve no cliniclly importnt negtive impct on erly CRRT delivery. This is n importnt finding since femorl ctheter insertion is sfer nd esier pproch for less experienced, junior doctors thn cnnultion of internl jugulr or subclvin veins. Strengths nd Limittions This study hs importnt strengths. All study dt, including highly detiled informtion on ctheter chrcteristics, insertion site nd CRRT dose were prospectively collected. In ddition, the lrge study size enbled djustment for numerous fctors such s ptient chrcteristics, ctheter fetures nd mode of nticogultion, which my potentilly ffect CRRT delivery. With such djustments, importnt prcticl observtions emerged, which cn be used to inform clinicl prctice. This study hs limittions. Choice of ctheter insertion site nd guge were not rndomized. However, our study provides the lrgest description of CRRT ctheter chrcteristics, guge nd site of insertion to dte nd detiled informtion to djust for mny key erly confounders. No informtion on ctheter tip plcement ws vilble. However, since longer ctheters were used in the femorl position nd since non-femorl ctheters were minly inserted in the right jugulr vein, it is likely tht most of the ctheters were positioned correctly. Our study does not provide informtion on the impct of insertion site or guge on CRRT delivery beyond the first complete 24 h. This ws, however, our intention since determinnts of CRRT dose unrelted to ccess, such s interruptions for investigtions, opertions nd mortlity would crete strong competing risk-relted confounding effect, given tht femorl ctheters were inserted in sicker ptients. By restricting the nlysis to the first complete 24 h of CRRT, we imed to diminish the impct of such confounders. Conclusions The femorl vein ws used s the first site of dilysis ctheter insertion in most ptients within the RENAL tril, especilly in lighter nd sicker ptients. Although such use of femorl ccess ws significntly ssocited with lower CRRT dose, the impct on dose ws limited. However, using lrger guge ctheter ws independently s- 16 Bellomo et l.
7 socited with the bility to deliver higher CRRT dose during the first 24 h. This informtion provides cliniclly relevnt informtion to ssist clinicins in their choice of preferred ccess site nd ctheter guge for the delivery of CRRT in criticlly ill ptients. Acknowledgments Contributions Reserch ide nd study design: R.B., A.C., M.G.; dt nlysis/interprettion: J.M., R.B., S.L.; sttisticl nlysis: S.L.; supervision nd mentorship: R.B.; drfting of mnuscript: J.M., K.M.K., R.B. Ech uthor contributed importnt intellectul content during mnuscript revision nd ccepts ccountbility for the overll work by ensuring tht questions pertining to the ccurcy or integrity of ny portion of the work re ppropritely investigted nd resolved. R.B. nd M.G. tke responsibility tht this study hs been reported honestly, ccurtely nd trnsprently; tht no importnt spects of the study hve been omitted nd tht ny discrepncies from the study s plnned hve been explined. Support nd Finncil Disclosure Declrtion This study ws supported by grnts from the Ntionl Helth nd Medicl Reserch Council (NHMRC) of Austrli (grnt ) nd Helth Reserch Council (HRC) of New Zelnd (grnt ). The study sponsors hd no role in study design; collection, nlysis, nd interprettion of dt; writing the report; or the decision to submit the report for publiction. Professor A. Css received funding from the Austrlin Ntionl Helth nd Medicl Reserch Council nd grnt support from Roche nd Gmbro. Professor R. Bellomo received consulting fees s n dvisor for Gmbro; nd consulted for Gmbro, Biosite, Abbott nd Philipps. Dr. M. Gllgher received honorri/speking fees from Roche. Dr. J. Mårtensson received trvel support to present reserch results t scientific meetings from Gmbro nd funding from Krolinsk Institutet. The remining uthors hve not disclosed ny potentil conflicts of interest. The George Institute hs received reserch funding from Servier, Novrtis, Eisi, Merck, Shrp & Dohme, Pfizer Austrli, Fresenius Kbi Deutschlnd GmbH nd Snofi Aventis. The RENAL Replcement Therpy Study is collbortion of the Austrlin nd New Zelnd Intensive Cre Society Clinicl Trils Group (ANZICS CTG) nd the George Institute for Interntionl Helth. References 1 Jonnidis M, Oudemns-vn Strten HM: Clinicl review: ptency of the circuit in continuous renl replcement therpy. Crit Cre 2007; 11: Prienti JJ, Mégrbne B, Fischer MO, Lutrette A, Gzui N, Mrin N, et l: Ctheter dysfunction nd dilysis performnce ccording to vsculr ccess mong 736 criticlly ill dults requiring renl replcement therpy: rndomized controlled study. Crit Cre Med 2010; 38: Beitlnd S, Sunde K, Moen H, Os I: Vribility in uremic control during continuous venovenous hemodifiltrtion in trum ptients. Crit Cre Res Prct 2012; 2012: Fely N, Bldwin I, Bellomo R: The effect of circuit down-time on uremic control during continuous veno-venous hemofiltrtion. Crit Cre Resusc 2002; 4: Morgn D, Ho K, Murry C, Dvies H, Louw J: A rndomized tril of ctheters of different lengths to chieve right trium versus superior ven cv plcement for continuous renl replcement therpy. Am J Kidney Dis 2012; 60: Dugué AE, Levesque SP, Fischer MO, Souweine B, Mir JP, Megrbne B, et l: Vsculr ccess sites for cute renl replcement in intensive cre units. Clin J Am Soc Nephrol 2012; 7: Kim IB, Fely N, Bldwin I, Bellomo R: Insertion side, body position nd circuit life during continuous renl replcement therpy with femorl vein ccess. Blood Purif 2011; 31: Lmeire N, Kellum JA: Contrst-induced cute kidney injury nd renl support for cute kidney injury: KDIGO summry (prt 2). Crit Cre 2013; 17: Finfer S, Css A, Gllgher M, Lee J, Su S, Bellomo R: The RENAL (rndomised evlution of norml vs. ugmented level of replcement therpy) study: sttisticl nlysis pln. Crit Cre Resusc 2009; 11: Bellomo R, Css A, Cole L, Finfer S, Gllgher M, Goldsmith D, et l: Design nd chllenges of the rndomized evlution of norml versus ugmented level replcement therpy (RENAL) tril: high-dose versus stndrddose hemofiltrtion in cute renl filure. Blood Purif 2008; 26: Bellomo R, Css A, Cole L, Finfer S, Gllgher M, Lo S, et l: Intensity of continuous renlreplcement therpy in criticlly ill ptients. N Engl J Med 2009; 361: Hryszko T, Brzosko S, Mzersk M, Mlyszko J, Mysliwiec M: Risk fctors of nontunneled noncuffed hemodilysis ctheter mlfunction. A prospective study. Nephron Clin Prct 2004; 96:c43 c Lingos O, Ro M, Ruthzer R, Blkrishnn VS, Modi G, Pereir BJ, et l: Fctors ssocited with ure reduction rtio in cute renl filure. Artif Orgns 2004; 28: Leblnc M, Fedk S, Mokris G, Pgnini EP: Blood recircultion in temporry centrl ctheters for cute hemodilysis. Clin Nephrol 1996; 45: Little MA, Conlon PJ, Wlshe JJ: Access recircultion in temporry hemodilysis ctheters s mesured by the sline dilution technique. Am J Kidney Dis 2000; 36: Mrozek N, Lutrette A, Timsit JF, Souweine B: How to del with dilysis ctheters in the ICU setting. Ann Intensive Cre 2012; 2: Prienti JJ, Thirion M, Mégrbne B, Souweine B, Ouchikhe A, Polito A, et l: Femorl vs jugulr venous ctheteriztion nd risk of nosocomil events in dults requiring cute renl replcement therpy: rndomized controlled tril. JAMA 2008; 299: Chu HR, Schneider AG, Sherry NL, Lotfy N, Chn MJ, Gltieri J, et l: Initil nd extended use of femorl versus nonfemorl double-lumen vsculr ctheters nd ctheter-relted infection during continuous renl replcement therpy. Am J Kidney Dis 2014; 64: Crosswell A, Brin MJ, Roodenburg O: Vsculr ccess site influences circuit life in continuous renl replcement therpy. Crit Cre Resusc 2014; 16: Femorl Access nd Delivery of CRRT Dose 17
Supplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationAnemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project
Kidney Interntionl, Vol. 64 (2003), pp. 1120 1124 Anemi in peditric hemodilysis ptients: Results from the 2001 ESRD Clinicl Performnce Mesures Project DIANE L. FRANKENFIELD, ALICA M. NEU, BRADLEY A. WARADY,
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationOriginal Paper. Med Princ Pract 2017;26: DOI: /
Originl Pper Med Princ Prct 2017;26:146 151 Received: Mrch 28, 2016 Accepted: December 6, 2016 Published online: December 6, 2016 The Assocition of Vitmin D Sttus nd Vitmin D Replcement Therpy with Glycemic
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More informationEmerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Emerging Options for Thromboprophylxis After Orthopedic Surgery: A Review of Clinicl Dt Bob L. Lobo, Phrm.D. In four rndomized, controlled studies of ptients undergoing orthopedic surgery, the ntithrombotic
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia
284 Anlysis of lterntives for izing ptients to chieve glycemic control nd void ccompnying risks of hypoglycemi JIALIN GAO 1,2*, QIANYIN XIONG 1,2*, JUN MIAO 1*, YAO ZHANG 2,3, LIBING XIA 1, MEIQIN LU 1,
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationPredictors of Hospitalization in Male Marine Corps Recruits with Exertional Heat Illness
MILITARY MEDICINE, 169, 3:169, 2004 Predictors of Hospitliztion in Mle Mrine Corps Recruits with Exertionl Het Illness Gurntor: COL John W. Grdner, MC FS USA Contributors: Shilp Hkre, DrPH; COL John W.
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationRelationship Between Hospital Performance on a Patient Satisfaction Survey and Surgical Quality
Reserch Originl Investigtion Reltionship Between Hospitl Performnce on Ptient Stisfction Survey nd Surgicl Qulity Greg D. Scks, MD, MPH; Elise H. Lwson, MD, MSHS; Aron J. Dwes, MD; Mrci M. Russell, MD;
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationRelationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients
J Renl Inj Prev. 2017; 6(2): 88-92. http://journlrip.com Journl of Renl Injury Prevention DOI: 10.15171/jrip.2017.17 Reltionship between serum irisin, glycemic indices, nd renl function in type 2 dibetic
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationOptimisation of diets for Atlantic cod (Gadus morhua) broodstock: effect of arachidonic acid on egg & larval quality
Optimistion of diets for Atlntic cod (Gdus morhu) roodstock: effect of rchidonic cid on egg & lrvl qulity Dr Gordon Bell, Ms. An Blnco, Dr Bill Roy, Dr Derek Roertson, Dr Jim Henderson nd Mr Richrd Prickett,
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationEuropean Journal of Internal Medicine
Europen Journl of Internl Medicine 22 (2011) 399 406 Contents lists vilble t ScienceDirect Europen Journl of Internl Medicine journl homepge: www.elsevier.com/locte/ejim Originl rticle Incidence of cute
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationEffect of Preoperative Intravenous Methocarbamol and Intravenous Acetaminophen on Opioid Use After Primary Total Hip and Knee Replacement
Feture Article Effect of Preopertive Intrvenous Methocrbmol nd Intrvenous Acetminophen on Opioid Use After Primry Totl Hip nd Knee Replcement THOMAS D. LOOKE, MD, PHD; CAMERON T. KLUTH, MBA bstrct Between
More informationImpact of left ventricular hypertrophy on survival in end-stage renal disease
Kidney Interntionl, Vol. 36 (1989), pp. 286 290 Impct of left ventriculr hypertrophy on survivl in end-stge renl disese JONATHAN S. SILBERBERG, PAUL E. BARRE, SARAH S. PRICHARD, nd ALLAN D. SNIDERMAN Divisions
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationT.S. Kurki a, *,U.Häkkinen b, J. Lauharanta c,j.rämö d, M. Leijala c
Europen Journl of Crdio-thorcic Surgery 20 (2001) 1183 1187 www.elsevier.com/locte/ejcts Evlution of the reltionship between preopertive risk scores, postopertive nd totl length of stys nd hospitl costs
More informationDrug Utilization Review of Potassium Chloride Injection Formulations Available in a Private Hospital in Kuching, Sarawak, Malaysia
Originl Article Drug Utiliztion Review of Potssium Chloride Injection Formultions Avilble in Privte Hospitl in Kuching, Srwk, Mlysi Mohmmd Hirmn Meliss 1, Srriff Azmi 2 Submitted: 24 Oct 2012 Accepted:
More informationPerioperative Hyperglycemia and Postoperative Infection after Lower Limb Arthroplasty
Journl of Dibetes Science nd Technology Volume 5, Issue 2, Mrch 2011 Dibetes Technology Society ORIGINAL ARTICLES Periopertive Hyperglycemi nd Postopertive Infection fter Lower Limb Arthroplsty Boris,
More informationRegression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study
(2004) 18, 403 409 & 2004 Nture Pulishing Group All rights reserved 0950-9240/04 $30.00 www.nture.com/jhh ORIGINAL ARTICLE Regression of electrocrdiogrphic left ventriculr hypertrophy predicts regression
More informationEsophageal carcinoma is the eighth most common cancer
ORIGINAL ARTICLE Tumor-Strom Rtio Is n Independent Predictor for Survivl in Esophgel Squmous Cell Crcinom Ki Wng, MD,* Wei M, MD,* Jinbo Wng, MD,* Ling Yu, MD, Xiomei Zhng, MD, Zhenbo Wng, MD, Bingxu Tn,
More informationPositive Heparin-Platelet Factor 4 Antibody Complex and Cardiac Surgical Outcomes
Positive Heprin-Pltelet Fctor 4 Antibody Complex nd Crdic Surgicl Outcomes Dvid C. Kress, MD, Solomon Aronson, MD, Monic L. McDonld, MD, Mohmmd I. Mlik, MD, Ajit B. Divgi, MD, Alfred J. Tector, MD, Frncis
More informationDose-dependent effect of daptomycin on the artificial prolongation of prothrombin time in coagulation abnormalities: in vitro verification
Hshimoto et l. BMC Phrmcology nd Toxicology (2017) 18:74 DOI 10.1186/s40360-017-0180-3 RESEARCH ARTICLE Open Access Dose-dependent effect of dptomycin on the rtificil prolongtion of prothrombin time in
More informationUniversity of Texas Health Science Center, San Antonio, San Antonio, Texas, USA
Lung Cncer Chemotherpy Given Ner the End of Life by Community Oncologists for Advnced Non-Smll Cell Lung Cncer Jose R. Murillo, Jr., Jim Koeller b,c Methodist Hospitl, Houston, Texs, USA; b University
More informationMuhammad Shoaib, Muhammad Usman, Rabia Fatima, Sajid Aziz, Muhammad Wasif Malik, Muhammad Javaid Asad and Sikandar Khan Sherwani
Americn-Eursin Journl of Toxicologicl Sciences 7 (4): 214-219, 2015 ISSN 2079-2050 IDOSI Publictions, 2015 DOI: 10.5829/idosi.ejts.2015.7.4.9447 Reltionship Among Alnine Amino-Trnsferse (ALT), Prtil Thromboplstin
More informationUS Food and Drug Administration-Mandated Trials of Long-Acting b -Agonists Safety in Asthma. Samy Suissa, PhD ; and Amnon Ariel, MD, FCCP
CHEST Commentry US Food nd Drug Administrtion-Mndted Trils of Long-Acting b -Agonists Sfety in Asthm Will We Know the Answer? Smy Suiss, PhD ; nd Amnon Ariel, MD, FCCP For 2 decdes, long-cting b -gonists
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationWSU Tree Fruit Research and Extension Center, Wenatchee (509) ext. 265;
FINAL REPORT WTFRC Project # AH-1-5 WSU Project # 13C-355-3 Project title: PI: Orgniztion: Coopertors: of Sunburn in Apples with RAYNOX Lrry Schrder, Horticulturist WSU Tree Fruit Reserch nd Extension
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationGlobal Intellectual Deficits in Cystinosis
Americn Journl of Medicl Genetics 49:83-87 (1994) Globl Intellectul Deficits in Cystinosis Brbr L.H. Willims, Jerry A. Schneider, nd Doris A. Truner Deprtments of Neurosciences (B.L.H.W.. D.A.T.) nd Peditrics
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationInhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD
CHEST Originl Reserch Inhled Corticosteroid Is Associted With n Incresed Risk of TB in Ptients With COPD Jung-Hyun Kim, MD ; Ji-Soo Prk, MD ; Kyung-Ho Kim, MD ; Hye-Cheol Jeong, MD ; Eun-Kyung Kim, MD
More informationFat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
Originl ppers Ft intke in ptients newly dignosed with type 2 dibetes: 4-yer follow-up study in generl prctice Floris A vn de Lr, Eloy H vn de Lisdonk, Peter L B J Lucssen, J M H Tigchelr, Sski Meyboom,
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationAcute Kidney Injury in Sub-Sahara Africa: A Single-Center Experience from Khartoum, Sudan
Originl Pper Advnces in CKD 2018 Published online: Jnury 26, 2018 Acute Kidney Injury in Sub-Shr Afric: A Single-Center Experience from Khrtoum, Sudn Dli E. Yousif Alice R. Topping b Mh F. Osmn Jochen
More informationSepsis is associated with mortality rates as high as 25%
Virl DNAemi nd Immune Suppression in Peditric Sepsis Sm Dvil, MD 1 ; E. Scott Hlsted, MD, PhD 2 ; Mrk W. Hll, MD 3 ; Alln Doctor, MD 1 ; Russell Telford, PhD 4 ; Richrd Holubkov, PhD 4 ; Joseph A. Crcillo,
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationAnalysis of Risk Factors for the Development of Incisional and Parastomal Hernias in Patients after Colorectal Surgery
Originl Article Journl of the Koren Society of J Koren Soc Coloproctol 2012;28(6):299-303 http://dx.doi.org/10.3393/jksc.2012.28.6.299 pissn 2093-7822 eissn 2093-7830 Anlysis of Risk Fctors for the Development
More informationProstate cancer is among the most common malignancies
Implictions of Evolving Delivery System Reforms for Prostte Cncer Cre Brent K. Hollenbeck, MD, MS; Mggie J. Bierlein, MS; Smuel R. Kufmn, MS; Lindsey Herrel, MD; Ted A. Skolrus, MD, MPH; Dvid C. Miller,
More informationURINARY incontinence is an important and common
Urinry incontinence in older people in the community: neglected problem? Helen Stoddrt, Jenny Donovn, Elise Whitley, Deborh Shrp nd In Hrvey SUMMARY Bckground: The prevlence nd impct of urinry incontinence
More informationORIGINAL RESEARCH & CONTRIBUTIONS
Effect of Advncing Age nd Multiple Chronic Conditions on Mortlity in Ptients with End-Stge Renl Disese fter Implntble Crdioverter-Defibrilltor Plcement Ashok Krishnswmi, MD, MAS; Mry-Lou Kiley, MBA; Fith
More informationEffects of physical exercise on working memory and prefrontal cortex function in post-stroke patients
Effects of physicl exercise on working memory nd prefrontl cortex function in post-stroke ptients M Moriy, C Aoki, K Sktni Grdute School of Helth Sciences Reserch, Mjor of Physicl Therpy, TeikyoHeisei
More informationA series of recent studies and meta-analyses confirm
Originl Reserch Clinicl Medicine & Reserch Volume 11, Number 4: 210-218 2013 Mrshfield Clinic clinmedres.org Brest nd Prostte Cncer Survivors in Dibetic Cohort: Results from the Living With Dibetes Study
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationRising costs have led to a number of federal initiatives to
Implictions of DRG Clssifiction in Bundled yment Inititive for COD TRISHA M. AREKH, DO; SURYA. BHATT, MD; ANDREW O. WESTFALL, MS; JAMES M. WELLS, MD; DENAY KIRKATRICK, DN, AN-BC; ANAND S. IYER, MD; MICHAEL
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationMortality of patients with multiple sclerosis: a cohort study in UK primary care
Mortlity of ptients with multiple sclerosis: cohort study in UK primry cre The Hrvrd community hs mde this rticle openly vilble. Plese shre how this ccess benefits you. Your story mtters Cittion Jick,
More informationA community-based comparison of trauma patient outcomes between D- and L-lactate fluids,
Americn Journl of Emergency Medicine (2013) 31, 206 214 www.elsevier.com/locte/jem Originl Contribution A community-bsed comprison of trum ptient outcomes between D- nd L-lctte fluids, Kzuki Kuwbr PhD,,
More informationHandgrip exercise elevates basilic venous hemodynamic parameters in healthy subjects
interntionl journl of nursing sciences 1 (2014) 389e393 Avilble online t www.sciencedirect.com ScienceDirect journl homepge: http://www.elsevier.com/journls/interntionljournl-of-nursing-sciences/2352-0132
More informationPrognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
Crcinogenesis, 2015, Vol. 36, No. 2, 243 248 doi:10.1093/crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of
More informationChilblains (pernio, perniosis) are cold-induced, painful or itching
Nifedipine vs Plcebo for Tretment of Chronic Chilblins: A Rndomized Controlled Tril Ibo H. Souwer, MD 1 Jcobus H. J. Bor, BSc (Mth) 2 Pul Smits, MD, PhD 3 Antoine L. M. Lgro-Jnssen, MD, PhD 1 1 Deprtment
More informationof comorbid conditions, interventions Diagnosis and treatment, treatment reduction of risk factors for CVD to slow disease progression,
Tble 5.1. NKF Clssifiction of Chronic Kidney Disese nd Clinicl Fetures Stge Description GFR (ml/ min/1.73 m 2 ) U.S. Prevlence, b # Affected (%) Clinicl Fetures Action Pln c At incresed risk for CKD >60
More informationMultiple sclerosis (MS) affects approximately. Triaging Patients with Multiple Sclerosis in the Emergency Department. Room for Improvement
Systemtic Review of Tools for Anxiety in MS MS CARE DELIVERY: CHALLENGES AND INVATIONS Triging Ptients with Multiple Sclerosis in the Emergency Deprtment Room for Improvement Heshm Abboud, MD, PhD; Krin
More informationRefining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
CHEST Originl Reserch Refining Clinicl Risk Strtifiction for Predicting Stroke nd Thromboembolism in Atril Fibrilltion Using Novel Risk Fctor-Bsed Approch The Euro Hert Survey on Atril Fibrilltion THROMBOEMBOLISM
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationDXA: Can It Be Used as a Criterion Reference for Body Fat Measurements in Children?
nture publishing group rticles methods AND techniques DXA: Cn It Be Used s Criterion Reference for Body Ft Mesurements in Children? Romn J. Shypilo 1, Nncy F. Butte 1 nd Kenneth J. Ellis 1 Objective: Dul-energy
More informationEffect of TCN2 776C G on vitamin B 12 cellular availability. end-stage renal disease patients
Kidney Interntionl, Vol. 64 (2003), pp. 1095 1100 Effect of TCN2 776C G on vitmin B 12 cellulr vilbility in end-stge renl disese ptients MANUELA FÖDINGER, MARIO VEITL, SONJA SKOUPY, JADWIGA WOJCIK, CLAUDIA
More informationPositive association between plasma homocysteine level and chronic kidney disease
University of Wollongong Reserch Online Fculty of Socil Sciences - Ppers Fculty of Socil Sciences 2008 Positive ssocition between plsm homocysteine level nd chronic kidney disese Anoop Shnkr Ntionl University
More informationSerum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study
Americn Journl of Nephrology Originl Report: Ptient-Oriented, Trnsltionl Reserch Received: April 27, 2016 Accepted: July 10, 2016 Published online: September 3, 2016 Serum Potssium Levels nd Mortlity in
More informationIncidence and Outcomes of Cardiopulmonary Resuscitation in PICUs
Peditric Criticl Cre Incidence nd Outcomes of Crdiopulmonry Resuscittion in PICUs Robert A. Berg, MD, FCCM, FAHA, FAAP 1 ; Viny M. Ndkrni, MD, FCCM, FAHA, FAAP 1 ; Amy E. Clrk, MS 2 ; Frnk Moler, MD 3
More informationProteinuria Is a Determinant of Quality of Life in Diabetic Nephropathy: Modeling Lagged Effects with Path Analysis
Americn Journl of Nephrology Originl Report: Ptient-Oriented, Trnsltionl Reserch DOI: 10.1159/000106672 Received: Mrch 26, 2007 Accepted: June 26, 2007 Published online: July 27, 2007 Proteinuri Is Determinnt
More informationRisk Factors and Outcomes Stratified by Severity of Acute Kidney Injury in Malaria
Risk Fctors nd Outcomes Strtified by Severity of Acute Kidney Injury in Mlri Kvith Srvu 1 *, Kumr Rishikesh 1, Chirg R. Prikh 2 * 1 Deprtment of Medicine, Ksturb Medicl College, Mnipl University, Mnipl,
More information8/1/2017. Correlating Radiomics Information with Clinical Outcomes for Lung SBRT. Disclosure. Acknowledgements
Correlting Rdiomics Informtion with Clinicl Outcomes for Lung SBRT Fng-Fng Yin, PhD Duke University Medicl Center AAPM 2017 Denver CO Disclosure This reserch is prtilly funded by reserch grnt from Vrin
More informationClinical statistics analysis on the characteristics of pneumoconiosis of Chinese miner population
Originl Article Clinicl sttistics nlysis on the chrcteristics of pneumoconiosis of Chinese miner popultion Mei-Fng Wng 1 *, Run-Ze Li 2 *, Ying Li 2, Xue-Qin Cheng 1, Jun Yng 1, Wen Chen 3, Xing-Xing Fn
More information